Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Nutrients|October 23, 2021
Feasibility and Efficiency of the BEFORE (Better Exercise and Food, Better Recovery) Prehabilitation ProgramThaís T T Tweed, Misha A T Sier, Ad A Van Bodegraven, et al.
Gut|March 26, 2013
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)Pieter Dewint, Bettina E Hansen, Elke Verhey, et al.
Journal of Cellular Biochemistry|April 27, 2012
Bone cells from patients with quiescent Crohn's disease show a reduced growth potential and an impeded maturationAngela E Oostlander, Nathalie Bravenboer, Huib W van Essen, et al.
Digestive Diseases (Basel, Switzerland)|February 7, 2019
Unmet Medical Needs in Ulcerative Colitis: An Expert Group ConsensusSilvio Danese, Matthieu Allez, Ad A van Bodegraven, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2015
Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic SurveillanceErik Mooiweer, Andrea E van der Meulen-de Jong, Cyriel Y Ponsioen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 27, 2010
Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitisDirk P van Asseldonk, Bindia Jharap, Dirk J Kuik, et al.
The Journal of Experimental Medicine|October 20, 2004
Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGNMathijs P Bergman, Anneke Engering, Hermelijn H Smits, et al.
Gastroenterology|September 22, 2010
Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's diseaseAngela E Oostlander, Nathalie Bravenboer, Evelien Sohl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agentsChristine Kestens, Martijn G H van Oijen, Charlotte L J Mulder, et al.
Clinical Nutrition ESPEN|May 24, 2021
Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admissionNicolette J Wierdsma, Hinke M Kruizenga, Lotte Aml Konings, et al.
Pageof 7